Huh Hoyoung

CIK 00014012679 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001401267

Recent Transactions

50 trades

Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase American Depositary Shares ("ADRs")
2025-12-16+618,658→ 618,658 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+618,658→ 618,658 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase ADRs
2025-12-16+3,093,293→ 3,093,293 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+3,093,293→ 3,093,293 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2025-06-05+30,000→ 30,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+225,000→ 225,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+175,000→ 175,000 total
Award
Akari Therapeutics Plc$AKTX
Series A Warrants (Right to Buy)
2025-03-06$1.12/sh+892,857→ 892,857 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-03-06$1.12/sh+892,857→ 4,695,854 total
Award
Akari Therapeutics Plc$AKTX
Series B Warrants (Right to Buy)
2025-03-06$1.12/sh+892,857→ 892,857 total
Disposition to Issuer
Peak Bio, Inc.
Common Stock
2024-11-14−4,574,661→ 0 total
Disposition to Issuer
Peak Bio, Inc.
Warrant (Right to Purchase)
2024-11-14−176,292→ 0 total
Conversion
Peak Bio, Inc.
Convertible Notes
2024-11-14→ 0 total
Disposition to Issuer
Peak Bio, Inc.
Common Stock
2024-11-14−372,940→ 0 total
Conversion
Peak Bio, Inc.
Common Stock
2024-11-14+4,574,661→ 4,574,661 total
Disposition to Issuer
Peak Bio, Inc.
Stock Option (Right to Buy)
2024-11-14−1,200,000→ 0 total
Disposition to Issuer
Peak Bio, Inc.
Common Stock
2024-11-14−8,382,742→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2024-06-13+26,764→ 26,764 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-21+45,000→ 8,382,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-20+30,000→ 8,337,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-19+50,000→ 8,307,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-15+25,000→ 8,257,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-14+20,000→ 8,232,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-13+30,000→ 8,212,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-12+17,000→ 8,182,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-09-11+30,000→ 8,165,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-31$0.27/sh+13,000→ 8,228,992 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-31+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30$0.26/sh+2,500→ 8,144,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30$0.25/sh+3,750→ 8,148,492 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30$0.26/sh+56,100→ 8,215,992 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30$0.27/sh+11,400→ 8,159,892 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30$0.25/sh+1,000→ 8,142,242 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-30+0→ 8,135,742 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-29$0.25/sh+5,500→ 8,141,242 total
Purchase
Peak Bio, Inc.
Common Stock
2023-08-29+0→ 8,135,742 total
Exercise of In-Money
Peak Bio, Inc.
Warrant (Right to Purchase)
2023-08-14−583,333→ 176,292 total
Exercise of In-Money
Peak Bio, Inc.
Common Stock
2023-08-14$0.60/sh+583,333→ 8,135,742 total
Exercise of In-Money
Peak Bio, Inc.
Common Stock
2023-07-20$0.60/sh+458,333→ 7,552,409 total
Exercise of In-Money
Peak Bio, Inc.
Warrant (Right to Purchase)
2023-07-20−458,333→ 759,625 total
Exercise of In-Money
Peak Bio, Inc.
Common Stock
2023-06-23$0.60/sh+666,667→ 7,094,076 total
Exercise of In-Money
Peak Bio, Inc.
Warrant (Right to Purchase)
2023-06-23−666,667→ 1,217,958 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-07+14,000→ 14,000 total
Award
Peak Bio, Inc.
Warrant (Right to Purchase)
2023-04-28+1,884,625→ 1,884,625 total
Award
Peak Bio, Inc.
Convertible Notes
2023-04-28$1130775.00/sh
Other
Peak Bio, Inc.
Common Stock
2022-11-01+6,442,438→ 6,422,438 total

Companies

Recent Filings

Address

C/O GERON CORPORATION 230 CONSTITUTION DRIVE

MENLO PARK, CA, 94025

View on SEC.gov